CD8A and metastatic neoplasm: Results show that a single intratumoral Mito‐FFa injection obviously induces CD8+ T cell‐mediated systemic antitumor immunity by coinducing calreticulin exposure and IFN‐I secretion and synergizes with anti‐PD‐L1 to control primary and metastatic tumors.